Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41587-024-02506-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biopharma innovation trends during COVID-19 and beyond: an evidence from global partnerships and fundraising activities, 2011-2022.
Global Health
August 2023
Department of Computer Science and Information Engineering, National Taiwan University, No. 1 Sec. 4, Roosevelt Road, Taipei, Taiwan.
Background: Co-development alliances and capital-raising activities are essential supports for biopharmaceutical innovation. During the initial outbreak of the COVID-19, the level of these business activities has increased greatly. Yet the magnitude, direction, and duration of the trend remain ambiguous.
View Article and Find Full Text PDFBIO-Europe Spring 2019 - 13th Annual International Partnering Conference (March 25-27, 2019 - Vienna, Austria).
Drugs Today (Barc)
May 2019
Clarivate Analytics, London, UK.
Vienna was the grand setting of the 13th Annual BIO-Europe Spring partnering meeting at the Congress Centre Wien, with receptions at the Hofburg Palace and the Rathaus. Thousands of biopharma executives congregated for one-to-one meetings to discuss collaborations, investment and the in- and outlicensing of assets. The three-day conference agenda included plenary sessions, company presentations, panel discussions, partnering workshops, networking lunches and spotlight sessions.
View Article and Find Full Text PDFLife sciences licensing deals in the second quarter of 2018: updates and trends.
Drugs Today (Barc)
October 2018
Clarivate Analytics, London, UK.
During the second quarter of 2018, Cortellis Competitive Intelligence registered 985 new deals (excluding mergers and acquisitions) with a total disclosed deal value of USD 19.5 billion as part of its ongoing coverage of licensing activity in the life sciences sector compared to 964 and USD 35.6 billion in the first quarter and 1,104 and USD 13.
View Article and Find Full Text PDFLife sciences licensing deals in the first quarter of 2018: updates and trends.
Drugs Today (Barc)
June 2018
Clarivate Analytics, Barcelona, Spain.
During the first quarter of 2018, Cortellis Competitive Intelligence registered 879 new deals (excluding mergers and acquisitions) with a total disclosed deal value of approximately USD 35.2 billion as part of its ongoing coverage of licensing activity in the life sciences sector. This compares to 1,203 and USD 26.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!